To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
March is Multiple Myeloma Awareness Month. Multiple myeloma is cancer of the plasma cells — a type of white blood cell in bone marrow. This disease is diagnosed in more African Americans than any other race in the United States. Jeffrey Zonder, M.D., leader of the Multiple Myeloma and Amyloidosis Multidisciplinary Team at Karmanos Cancer Institute, joins the Leukemia & Lymphoma Society – Michigan Chapter, a multiple myeloma survivor, and The Detroit Praise Network’s Michael Van Tull for a discussion on the disease. They discuss how it affects the African American community and the signs and systems you should not ignore.
Your browser does not support the audio element.
Download Podcast